MicroPort CardioFlow Medtech Corporation (HKG:2160)
1.660
-0.030 (-1.78%)
May 29, 2026, 4:08 PM HKT
HKG:2160 Revenue
In the year 2025, MicroPort CardioFlow Medtech had annual revenue of $57.04M USD with 12.28% growth. MicroPort CardioFlow Medtech had revenue of $12.14M in the quarter ending December 31, 2025, with 20.04% growth.
Revenue
$57.04M
Revenue Growth
+12.28%
P/S Ratio
4.76
Revenue / Employee
$136.80K
Employees
417
Market Cap
2.11B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.04M | 6.24M | 12.28% |
| Dec 31, 2024 | 50.81M | 3.39M | 7.15% |
| Dec 31, 2023 | 47.41M | 11.02M | 30.28% |
| Dec 31, 2022 | 36.40M | 4.78M | 15.13% |
| Dec 31, 2021 | 31.61M | 15.69M | 98.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Isotope & Radiation | 8.00B |
| Sisram Medical | 2.84B |
| Gaush Meditech | 1.54B |
| MicroPort NeuroScientific | 879.66M |
| Peijia Medical | 793.29M |
| MicroTech Medical (Hangzhou) | 735.33M |
| Acotec Scientific Holdings | 717.35M |
| LEPU ScienTech Medical Technology (Shanghai) | 587.50M |